Vanguard Personalized Indexing Management’s Maravai LifeSciences MRVI Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11,586	Closed	-$409K	–	1306
2022 Q1	$409K	Buy	11,586 +6,680	+136%	+$224K	0.02%	902
2021 Q4	$206K	Sell	4,906 -2,023	-29%	-$81.9K	0.01%	991
2021 Q3	$340K	Buy	6,929 +102	+1%	+$4.97K	0.03%	713
2021 Q2	$285K	Buy	+6,827	New	+$265K	0.03%	754

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Personalized Indexing Management's MRVI Position: Q2 2022 in Review

Vanguard Personalized Indexing Management sold out of Maravai LifeSciences (MRVI) in Q2 2022, closing a stake of 11,586 shares — an estimated $409K sold.

Vanguard Personalized Indexing Management first reported a position in MRVI in Q2 2021 and held it in 4 quarters. The position peaked at $409K in Q1 2022. 216 funds tracked by Wall St. Rank hold MRVI as of Q2 2022.

Vanguard Personalized Indexing Management reported no remaining Maravai LifeSciences position as of Q2 2022 after selling out during the quarter.
Vanguard Personalized Indexing Management sold 11,586 Maravai LifeSciences shares in Q2 2022, an estimated $409K.
Vanguard Personalized Indexing Management first reported a position in Maravai LifeSciences in Q2 2021 and held it in 4 quarters.
Vanguard Personalized Indexing Management's Maravai LifeSciences position peaked at $409K in Q1 2022.
216 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2022.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2022, filed 9 Aug 2022.